Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
7
7 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- obudanersenION582Phase 33 trials
Ionis Pharmaceuticals · Angelman Syndrome
- SapablursenISIS 702843, ONO-0530Phase 32 trials
Ono Pharmaceutical Co., Ltd. · Polycythemia Vera, Phlebotomy Dependent Polycythemia Vera
- ION363Phase 31 trial
Ionis Pharmaceuticals · Amyotrophic Lateral Sclerosis
- ION337Phase 21 trial
Ionis Pharmaceuticals · Dravet Syndrome
- ION440Phase 21 trial
Ionis Pharmaceuticals · Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
- ION717Phase 21 trial
Ionis Pharmaceuticals · Prion Disease
- ION775Phase 21 trial
Ionis Pharmaceuticals · Hypertriglyceridemia, Severe Hypertriglyceridemia
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.